“…Tetrazine-based fluorogenic labels attract significant attention across various research communities in life sciences, − due to their exceptional combinations of several favorable properties: outstanding chemoselectivity, excellent biocompatibility, tunable optical properties, and distinctive fluorescence enhancement (FE) effects. − Typically, these labels exhibit minimal fluorescence in the presence of tetrazine moiety. However, a significant increment in fluorescence is observed upon tetrazine disintegrations via click reactions. − This unique fluorogenic effect significantly improves signal-to-noise ratios, leading to widespread utilization in bioimaging, − drug delivery, − as well as pathophysiological diagnostics and therapy. − However, a key challenge lies in the fact that most labels with high FE ratios primarily emit in the visible region, with a diminishing FE as the emission wavelengths shift into the deep-red and near-infrared (NIR) regions. − Therefore, developing new strategies to enhance FE ratios, particularly for NIR-emitting labels, is crucial for optimizing their fluorogenicity.…”